Collections in this community

Recent Submissions

1. PATIENT AND CAREGIVER SPINAL MUSCULAR ATROPHY (SMA) TREATMENT ATTRIBUTE PREFERENCES IN LATIN AMERICA

   VALUE IN HEALTH, v.26, n.6, suppl.S, p.S239-S239, 2023

2. LOXL3 knock out affects pathways which involve cytoskeleton regulation, proliferation and apoptosis in glioblastoma cells

   CANCER RESEARCH, v.83, n.7, suppl.S, 2023

3. Hemifacial Spasm: gene expression and immunohistochemical analysis

   INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, v.64, n.8, article ID 4081, 3p, 2023

4. Metabolic and Structural Signatures in Corticobasal Syndrome: A Multimodal PET/MRI Study

   BIOPHYSICAL REVIEWS, v.13, n.6, Special Issue, p.1471-1471, 2021

5. Epigenetic dedifferentiation as a therapeutic strategy in adrenal cancer

   CANCER RESEARCH, v.83, n.7, suppl.S, 2023

6. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries

   INTERNATIONAL JOURNAL OF STROKE, v.18, n.9, p.1112-1120, 2023

   Background: Adenovirus-based COVID-19 vaccines are extensively used in low- and middle-income countries (LMICs). Remarkably, cases of cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia (CVST-VITT) have rarely been reported from LMICs. Aims: We studied the f...

7. Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer's disease pathology: a population-based autopsy study in an admixed sample

   ACTA NEUROPATHOLOGICA COMMUNICATIONS, v.11, n.1, article ID 205, 10p, 2023

   Background: Apolipoprotein E epsilon 4 allele (APOE-epsilon 4) is the main genetic risk factor for late-onset Alzheimer's disease (AD) and may impact cognitive function also via other neuropathological lesions. However, there is limited evidence available from diverse populations, as APOE associa...

8. Biomarkers for dementia in Latin American countries: Gaps and opportunities

   ALZHEIMERS & DEMENTIA, v.19, n.2, p.721-735, 2023

   Limited knowledge on dementia biomarkers in Latin American and Caribbean (LAC) countries remains a serious barrier. Here, we reported a survey to explore the ongoing work, needs, interests, potential barriers, and opportunities for future studies related to biomarkers. The results show that neuro...

9. The past, present and future of Alzheimer's disease - part 1: the past

   ARQUIVOS DE NEURO-PSIQUIATRIA, v.81, n.12, p.1070-1076, 2023

   Background Alzheimer's disease (AD) was described in 1907, and since then it changed from a relatively rare condition to one of the most prevalent diseases.Objective To describe the evolution of the notions of dementias and AD, and to investigate the reasons for the increase in scientific interes...

10. Measurement of resistance-area product by transcranial Doppler: An alternative tool for cognitive screening in hypertensive on drug treatment?

    CEREBRAL CIRCULATION-COGNITION AND BEHAVIOR, v.5, article ID 100191, 7p, 2023

    Introduction: Arterial hypertrophy and remodeling are adaptive responses present in systemic arterial hyper-tension that can result in silent ischemia and neurodegeneration, compromising brain connections and cognitive performance (CP). However, CP is affected differently over time, so traditiona...